• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结核分枝杆菌肺病的医学管理

Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.

作者信息

Philley Julie V, Griffith David E

机构信息

Pulmonary and Critical Care Medicine, The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX 75708, USA.

Pulmonary and Critical Care Medicine, The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX 75708, USA.

出版信息

Thorac Surg Clin. 2019 Feb;29(1):65-76. doi: 10.1016/j.thorsurg.2018.09.001.

DOI:10.1016/j.thorsurg.2018.09.001
PMID:30454923
Abstract

Nontuberculous mycobacterial (NTM) lung infections are increasingly recognized as a cause of chronic pulmonary disease. This article focuses on the most common NTM species known to cause human lung disease and the treatment options currently available. The diagnosis of NTM lung disease is also discussed, emphasizing the necessity for treating clinicians to have sufficient familiarity of the mycobacteria laboratory to provide optimal patient management.

摘要

非结核分枝杆菌(NTM)肺部感染日益被认为是慢性肺病的一个病因。本文重点关注已知可导致人类肺部疾病的最常见NTM菌种以及目前可用的治疗选择。还讨论了NTM肺病的诊断,强调临床医生必须充分熟悉分枝杆菌实验室,以便为患者提供最佳管理。

相似文献

1
Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.非结核分枝杆菌肺病的医学管理
Thorac Surg Clin. 2019 Feb;29(1):65-76. doi: 10.1016/j.thorsurg.2018.09.001.
2
Management of nontuberculous mycobacterial (NTM) lung disease.非结核分枝杆菌(NTM)肺病的管理。
Semin Respir Crit Care Med. 2013 Feb;34(1):135-42. doi: 10.1055/s-0033-1333575. Epub 2013 Mar 4.
3
Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.非结核分枝杆菌肺病一年改善情况的预测因素:一项为期11年的回顾性多中心研究。
PLoS Negl Trop Dis. 2017 Aug 7;11(8):e0005841. doi: 10.1371/journal.pntd.0005841. eCollection 2017 Aug.
4
Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病的微生物学诊断。
Clin Chest Med. 2015 Mar;36(1):43-54. doi: 10.1016/j.ccm.2014.11.005. Epub 2014 Dec 18.
5
Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials.非结核分枝杆菌(NTM)肺病:十大要点
Respir Med. 2014 Mar;108(3):417-25. doi: 10.1016/j.rmed.2013.09.014. Epub 2013 Sep 25.
6
Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).介绍新的 BTS 指南:非结核分枝杆菌肺部疾病(NTM-PD)的管理。
Thorax. 2017 Nov;72(11):969-970. doi: 10.1136/thoraxjnl-2017-210929.
7
Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.非结核分枝杆菌(NTM)肺部感染以患者为中心的研究重点。一份NTM研究联盟研讨会报告。
Ann Am Thorac Soc. 2016 Sep;13(9):S379-84. doi: 10.1513/AnnalsATS.201605-387WS.
8
Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review.肺部非结核分枝杆菌感染的当前挑战:病例系列及文献复习。
Postgrad Med. 2024 Sep;136(7):770-781. doi: 10.1080/00325481.2024.2401766. Epub 2024 Sep 12.
9
Recent advances in nontuberculous mycobacterial lung infections.非结核分枝杆菌肺部感染的最新进展
F1000Res. 2019 Oct 1;8. doi: 10.12688/f1000research.20096.1. eCollection 2019.
10
Nontuberculous Mycobacteria-Overview.非结核分枝杆菌概述。
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0024-2016.

引用本文的文献

1
Clinical Characteristics of Patients with Nontuberculous Mycobacterium Pulmonary Disease in Fuyang, China: A Retrospective Study.中国阜阳非结核分枝杆菌肺病患者的临床特征:一项回顾性研究
Infect Drug Resist. 2024 Sep 14;17:3989-4000. doi: 10.2147/IDR.S475652. eCollection 2024.
2
Infection of Hilar and Mediastinal Lymph Nodes: A Case Report and Literature Review.肺门及纵隔淋巴结感染:一例报告及文献复习
Infect Drug Resist. 2023 Nov 21;16:7305-7311. doi: 10.2147/IDR.S432987. eCollection 2023.
3
Synthesis of Novel Benzenesulfonamide-Bearing Functionalized Imidazole Derivatives as Novel Candidates Targeting Multidrug-Resistant Complex.
新型含苯磺酰胺官能化咪唑衍生物的合成作为靶向多药耐药复合物的新型候选物
Microorganisms. 2023 Apr 3;11(4):935. doi: 10.3390/microorganisms11040935.
4
MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study.MGIT-seq 技术用于鉴定非结核分枝杆菌及其耐药性:一项前瞻性研究。
J Clin Microbiol. 2023 Apr 20;61(4):e0162622. doi: 10.1128/jcm.01626-22. Epub 2023 Mar 22.
5
Rapid and Comprehensive Identification of Nontuberculous Mycobacteria.快速全面鉴定非结核分枝杆菌。
Methods Mol Biol. 2023;2632:247-255. doi: 10.1007/978-1-0716-2996-3_17.
6
Pulmonary disease caused by a newly identified mycobacterium: Mycolicibacterium toneyamachuris: a case report.由一种新鉴定的分枝杆菌引起的肺部疾病:土分枝杆菌:病例报告。
BMC Infect Dis. 2020 Nov 25;20(1):888. doi: 10.1186/s12879-020-05626-y.
7
Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients.免疫功能低下患者中由非结核分枝杆菌和真菌引起的机会性合并感染
Antibiotics (Basel). 2020 Nov 2;9(11):771. doi: 10.3390/antibiotics9110771.
8
Looking beyond Typical Treatments for Atypical Mycobacteria.探寻非典型分枝杆菌的非传统治疗方法。
Antibiotics (Basel). 2020 Jan 3;9(1):18. doi: 10.3390/antibiotics9010018.
9
Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.中国南京地区非结核分枝杆菌肺病的特征。
BMC Infect Dis. 2019 Sep 2;19(1):764. doi: 10.1186/s12879-019-4412-6.
10
Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study.16S rRNA 基因 pan 分枝杆菌 PCR 对非结核分枝杆菌感染的诊断价值:一项 10 年回顾性研究。
Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1873-1881. doi: 10.1007/s10096-019-03621-z. Epub 2019 Jul 16.